Treatment Practices for Adults With Candidemia at 9 Active Surveillance Sites—United States, 2017–2018

Abstract

A substantial proportion of patients with candidemia were initially treated with fluconazole, resulting in potentially inappropriate treatment for those involving non-albicans or fluconazole-resistant species. Reasons for nonadherence to IDSA guidelines should be evaluated, and clinician education is needed.